![Photochemical Activation of Enediyne Warheads: A Potential Tool for Targeted Antitumor Therapy | Molecular Pharmaceutics Photochemical Activation of Enediyne Warheads: A Potential Tool for Targeted Antitumor Therapy | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.7b00911/asset/images/large/mp-2017-00911r_0001.jpeg)
Photochemical Activation of Enediyne Warheads: A Potential Tool for Targeted Antitumor Therapy | Molecular Pharmaceutics
Synthetic calicheamicin mimics with novel initiation mechanisms: DNA cleavage, cytotoxicity, and apoptosis
![A Total Synthesis Trilogy: Calicheamicin γ1I, Taxol®, and Brevetoxin A - Nicolaou - 2012 - The Chemical Record - Wiley Online Library A Total Synthesis Trilogy: Calicheamicin γ1I, Taxol®, and Brevetoxin A - Nicolaou - 2012 - The Chemical Record - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ab36f0a0-fc73-4e21-9d95-592ba20fcef7/mfig002.jpg)
A Total Synthesis Trilogy: Calicheamicin γ1I, Taxol®, and Brevetoxin A - Nicolaou - 2012 - The Chemical Record - Wiley Online Library
![Structural and conformational features relevant to the anti‐tumor activity of calicheamicin γ - Ellestad - 2011 - Chirality - Wiley Online Library Structural and conformational features relevant to the anti‐tumor activity of calicheamicin γ - Ellestad - 2011 - Chirality - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eb574d23-b88f-4734-b723-e3863f5ce5d2/msch001.jpg)
Structural and conformational features relevant to the anti‐tumor activity of calicheamicin γ - Ellestad - 2011 - Chirality - Wiley Online Library
![The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells | Leukemia The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fleu.2011.206/MediaObjects/41375_2012_Article_BFleu2011206_Fig7_HTML.jpg)
The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells | Leukemia
![Proposed mechanism of action for calicheamicin, an enediyne antitumor... | Download Scientific Diagram Proposed mechanism of action for calicheamicin, an enediyne antitumor... | Download Scientific Diagram](https://www.researchgate.net/publication/260407766/figure/fig2/AS:297045433831424@1447832558027/Proposed-mechanism-of-action-for-calicheamicin-an-enediyne-antitumor-drug.png)